HIGH PREVALENCE OF METABOLIC DISORDERS IN PSORIASIS PATIENTS
Journal Title: Romanian Journal of Diabetes Nutrition and Metabolic Diseases - Year 2011, Vol 18, Issue 4
Abstract
Recent studies have shown that psoriasis is a systemic disorder associated with an increased prevalence of metabolic anomalies. This study compares the prevalence of obesity and metabolic disorders in psoriasis patients and the general population. 302 patients and 621 controls were included in a retrospective case control study. We compared the proportion of obesity, diabetes, and dyslipidemia between case and control groups. Psoriasis patients had higher odds of diabetes (OR 1.97; 95% CI, 1.36-2.86), dyslipidemia (OR 1.76; 95% CI, 1.31-2.37), and obesity (OR 2.84; 95% CI 1.87-4.31) compared with controls. The risk of dyslipidemia and obesity correlated with disease severity. The long term management of psoriasis patients should address not only the cutaneous and joint manifestations, but also the prevention and correction of eventual associated metabolic disorders.
Authors and Affiliations
Liliana Popa, Aura Reghina, F Sandru, V Perlea, Simona Fica, C Giurcaneanu
Keywords
Related Articles
- EP ID EP103117
- DOI -
- Views 135
- Downloads 0
FEEDING, BIRTH WEIGHT AND RANK INFLUENCE ON THE RISK OF DIABETES MELLITUS IN CHILDREN
Background: The etiology of type 1 diabetes mellitus supposes the existence of genetic factors, but also environmental ones, of nutritional, fetal (e.g. birth weight) perinatal nature. This study aims at identifying food...
Glucose Variability In Persons With Diabetes Evaluated By Continuous Glucose Monitoring
Blood glucose level is the main indicator of diabetes control. It is related to diabetes evolution and appearance of chronic complications. Daily and/or postprandial glucose fluctuations induce oxidative stress and endot...
HEPATIC STEATOSIS IN PATIENTS WITH HEPATITIS C
Aims: The aims of this study was to indentify independent predictive factors of liver steatosis in patients with hepatitis C and to examine the correlations between ultrasound-diagnosed HS and anthropometric, clinical, b...
PATHOGENESIS OF TYPE 1 DIABETES MELLITUS: A BRIEF OVERVIEW
Before the discovery of insulin, type 1 diabetes mellitus (DM) was a disease with acute evolution, leading to death shortly after diagnosis. During the first years of insulin therapy, the medical world was optimist...
THERAPY WITH GLP-1 AGONISTS AND DIPEPTIDYL-PEPTIDASE IV INHIBITORS IN TYPE 2 DIABETES MELLITUS
Since type 2 diabetes is increasing and most patients do not reach their therapeutic goals, novel treatment options are needed. The novel therapeutic options for type 2 diabetes mellitus (Type 2 DM); respectively those b...